Combination of Mycophenolate Mofetil and Tacrolimus for Refractory Lupus Nephritis: A 12-Month Open-Labeled Trial.

被引:0
作者
Mok, Chi Chiu [1 ]
Chan, Pak To [1 ]
Ho, Ling Yin [1 ]
Yu, Ka Lung [1 ]
机构
[1] Tuen Mun Hosp, Hong Kong, Hong Kong, Peoples R China
来源
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1414
引用
收藏
页码:S608 / S609
页数:2
相关论文
共 48 条
[31]   A Prospective Randomized, Comparative Trial of High-Dose Mizoribine versus Mycophenolate Mofetil in Combination with Tacrolimus and Basiliximab for Living Donor Renal Transplantation: A Multi-Center Trial. [J].
Ishida, H. ;
Tanabe, K. ;
Takahara, S. ;
Amada, N. ;
Takahashi, K. ;
Toma, H. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 :620-620
[32]   Combination of interferon alpha 2b plus ribavirin for the treatment of chronic hepatitis C: Preliminary results of an open-labeled community trial. [J].
Lewis, JH ;
Gallagher, JG ;
Gibbs, L ;
Epstein, ME .
HEPATOLOGY, 1997, 26 (04) :1680-1680
[33]   A 12-MONTH, OPEN-LABEL TRIAL OF FLIBANSERIN IN NORTH AMERICAN WOMEN WITH GENERALIZED ACQUIRED HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD): THE SUNFLOWER TRIAL. [J].
Jayne, C. ;
Simon, J. ;
Taylor, L. ;
Kimura, T. ;
Pyke, R. ;
Lesko, L. ;
Simon, James A. .
FERTILITY AND STERILITY, 2010, 94 (04) :S13-S14
[34]   Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients [J].
de Boer, S. E. ;
Sanders, J. S. F. ;
Bemelman, F. J. ;
Betjes, M. G. H. ;
Burgerhof, J. G. M. ;
Hilbrands, L. ;
Kuypers, D. ;
van Munster, B. C. ;
Nurmohamed, S. A. ;
de Vries, A. P. J. ;
van Zuilen, A. D. ;
Hesselink, D. A. ;
Berger, S. P. .
BMC NEPHROLOGY, 2021, 22 (01)
[35]   TOLERABILITY AND RENAL SPARING OF MYCOPHENOLATE MOFETIL MMF/SIROLIMUS (SRL) MAINTENANCE THERAPY IN LIVER TRANSPLANT RECIPIENTS: 12-MONTH RESULTS OF THE SPARE-THE-NEPHRON (STN) TRIAL [J].
Teperman, L. ;
Marotta, P. ;
Sher, L. ;
Sebastian, A. ;
Moonka, D. ;
Patel, D. ;
Koneru, B. .
LIVER TRANSPLANTATION, 2008, 14 (07) :S224-S224
[36]   Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients [J].
S. E. de Boer ;
J. S.F. Sanders ;
F. J. Bemelman ;
M. G.H. Betjes ;
J. G.M. Burgerhof ;
L. Hilbrands ;
D. Kuypers ;
B. C. van Munster ;
S. A. Nurmohamed ;
A. P.J. de Vries ;
A. D. van Zuilen ;
D. A. Hesselink ;
S. P. Berger .
BMC Nephrology, 22
[37]   12 month results of a multicenter, randomized trial comparing three induction agents (alemtuzumab, thymoglobulin and basiliximab) with tacrolimus, mycophenolate mofetil and a rapid steroid withdrawal in renal transplantation. [J].
Hanaway, Michael ;
Woodle, E. Steve ;
Mulgaonkar, Shamkant ;
Peddi, Ram ;
Harrison, Gilda ;
Vandeputte, Karen ;
Fitzsimmons, William ;
First, Roy ;
Holman, John .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 :215-215
[38]   Hydroxychloroquine blood levels in stable lupus nephritis under low dose (2–3 mg/kg/day): 12-month prospective randomized controlled trial [J].
Caio B. Zanetti ;
Tatiana Pedrosa ;
Léonard de V. K. Kupa ;
Nadia E. Aikawa ;
Eduardo F. Borba ;
Margarete B. G. Vendramini ;
Clovis A. Silva ;
Sandra G. Pasoto ;
Eloisa Bonfa .
Clinical Rheumatology, 2021, 40 :2745-2751
[39]   Preliminary results of an open randomised clinical trial comparing mycophenolate mofetil (MMF) vs. intravenous cyclophosphamide (IV-CYC) as induction therapy for severe lupus nephritis (LN) [J].
Flores-Suarez, LF ;
Villa, AR .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 :229-230
[40]   Hydroxychloroquine blood levels in stable lupus nephritis under low dose (2-3 mg/kg/day): 12-month prospective randomized controlled trial [J].
Zanetti, Caio B. ;
Pedrosa, Tatiana ;
Kupa, Leonard de V. K. ;
Aikawa, Nadia E. ;
Borba, Eduardo F. ;
Vendramini, Margarete B. G. ;
Silva, Clovis A. ;
Pasoto, Sandra G. ;
Bonfa, Eloisa .
CLINICAL RHEUMATOLOGY, 2021, 40 (07) :2745-2751